Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma

American Journal of Pathology

Volumn 149, Issue 3, 1996, Pages 883-893

  Van Elsas, Andrea ^a   Zerp, Shuraila F ^a   Van Der Flier, Silvia ^a   Krüse, K Margreet ^a   Aarnoudse, Corlien ^a   Hayward, Nicholas K ^b   Ruiter, Dirk J ^c   Schrier, Peter I ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; HUMAN; HUMAN TISSUE; MELANOMA; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE RAS; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN CANCER; SKIN CARCINOGENESIS; SUN EXPOSURE; ULTRAVIOLET RADIATION;

BASE SEQUENCE; DNA, NEOPLASM; GENES, RAS; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; PARAFFIN EMBEDDING; POINT MUTATION; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 0029781017     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Elwood JM, Koh HK: Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin Oncol 1994, 6:179-187
2. Armstrong BK, Kricker A: Cutaneous melanoma. Cancer Surv 1994, 19:219-240
3. Nelemans PJ, Kiemeney LALM, Rampen FHJ, Straatman H, Verbeek ALM: Trends in mortality from malignant cutaneous melanoma in The Netherlands, 1950-1988, Eur J Cancer 1993, 29A:107-111
4. Streetly A, Markowe H: Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol 1995, 24:897-907
5. Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, McLean DI, Threlfall WJ: Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995, 131:164-169
6. Kraemer KH, Lee MM, Scotto J: Xeroderma pigmentosum: cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987, 123:241-250
7. Holman CDJ, Armstrong BK: Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic subtypes. J Natl Cancer Inst 1984, 73:75-82
8. MacKie RM: The role of sunlight in the etiology of cutaneous malignant melanoma. Clin Exp Dermatol 1981, 6:407-410
9. Holman CD, Armstrong BK, Heenan PJ: Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986, 76:403-414
10. Elwood JM, Gallagher RP, Hill GB, Pearson JCG: Cutaneous melanoma in relation to intermittent and constant sun exposure: the Western Canada melanoma study, Int J Cancer 1985, 35:427-433
11. MacKie RM, McHenry P, Hole D: Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet 1993, 341: 1618-1620
12. Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Holzman I, Orfanos CE: Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society. J Invest Dermatol 1994, 102:695-699
13. Ananthaswamy HN, Price JE, Goldberg LH, Bales ES: Detection and identification of activated oncogenes in human skin tumors occurring on sun-exposed body sites. Cancer Res 1988, 48:3341-3346
14. Van der Schroeff JG, Evers LM, Boot AJM, Bos JL: ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J Invest Dermatol 1990, 94:423-425
15. Brash DE, Rudolph JA, Simon JA, Lin A, Mckenna GJ, Baden HP, Halperin AJ, Ponten J: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991, 88: 10124-10128
16. Harris CC: Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res 1991, 51:S5023-S5044
17. Ziegler A, Jonason AS, Lefell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T, Brash DE: Sunburn in the onset of skin cancer. Nature 1995, 372:773-776
18. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L: Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma-pigmentosum patients. Proc Natl Acad Sci USA 1993, 90:10529-10533
19. Daya-Grosjean L, Robert C, Drougard C, Suarez H, Sarasin A: High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xerodermapigmentosum patients. Cancer Res 1993, 53:1625-1629
20. Keijzer W, Mulder MP, Langeveld JC, Smit EM, Bos JL, Bootsma D, Hoeijmakers JH: Establishment and characterization of a melanoma cell line from a xeroderma pigmentosum patient: activation of N-ras at a potential pyrimidine dimer site. Cancer Res 1989, 49:1229-1235
21. Van der Lubbe JL, Rosdorff HJ, Bos JL, Van der Eb AJ: Activation of N-ras induced by ultraviolet irradiation in vitro. Oncogene Res 1988, 3:9-20
22. Pierceall WE, Ananthaswamy HN: Transformation of NIH3T3 cells by transfection with UV-irradiated human c-Ha-ras-1 proto-oncogene DNA. Oncogene 1991, 6:2085-2091
23. Nishigori C, Wang S, Miyakoshi J, Sato M, Tsukada T, Yagi T, Imamura S, Takebe H: Mutations in ras genes in cells cultured from mouse skin tumors induced by ultraviolet irradiation. Proc Natl Acad Sci USA 1994, 91: 7189-7193
24. Albino AP, Le Strange R, Oliff AI, Furth ME, Old LJ: Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? Nature 1984, 308: 69-72
25. Sekiya T, Fushimi M, Hori H, Hirohashi S, Nishimura S, Sugimura T: Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient. Proc Natl Acad Sci USA 1984, 81:4771-4775
26. Padua RA, Barrass NC, Currie GA: Activation of N-ras in a human melanoma cell line. Mol Cell Biol 1985, 5:582-585
27. Raybaud F, Noguchi T, Marics I, Adelaide J, Planche J, Batoz M, Aubert C, de Lapeyriere O, Birnbaum D: Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay. Cancer Res 1988, 48:950-953
28. Albino AP, Nanus DM, Mentle IR, Cordon-Cardo C, McNutt NS, Bressler J, Andreeff M: Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene 1989, 4:1363-1374
29. van 't Veer LJ, Burgering BMT, Versteeg R, Boot AJM, Ruiter DJ, Osanto S, Schrier PI, Bos JL: N-ras mutations in human cutaneous melanoma on sun-exposed body sites. Mol Cell Biol 1989, 9:3114-3116
30. Shukla VK, Hughes DC, Hughes LE, McCormick F, Padua RA: ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development. Oncogene Res 1989, 5:121-127
31. Ball NJ, Yohn JJ, Morelli JG, Norris DA, Golitz LE, Hoeffler JP: ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol 1994, 102:285-290
32. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim van Dillen PM, van der Noordaa J: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990, 28:495-503
33. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T: Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1990, 5:1037-1043
34. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989, 86:2766-2770
35. H genes mutated at codon 61. Cell 1986, 44:167-176
36. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D: Germ-line mutations in the Wilms tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991, 67:437-447
37. Murakami Y, Hayashi K, Hirohashi S, Sekiya T: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991, 51:5520-5525
38. Bos JL: ras oncogenes in human cancer a review. Cancer Res 1989, 49:4682-4689
39. Seeburg PH, Colby WW, Capon DJ, Goeddel DV, Levinson AD: Biological properties of human c-Ha-ras-1 genes mutated at codon 12. Nature 1984, 312: 71-75
40. Trahey M, McCormick F: A cytoplasmic protein stimulates normal N-ras p21 GTPase but does not affect oncogenic mutants. Science 1987, 238:542-545
41. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruch H, Conroy L, Clark R, O'Connel P, Cawthon RM, Innis MA, McCormick F: The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990, 63:843-849
42. Feig LA, Cooper GM: Relationship among nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins. Mol Cell Biol 1988, 8:2472-2478
43. Schrier PI, van 't Veer LJ, Bergman W: Human melanoma genetics: involvement of oncogenes and tumor suppressor genes. Malignant Melanoma: Medical and Surgical Management. Edited by FJ Lejeune, PK Chauduri, TK Das Gupta. New York, McGraw Hill, 1994, 51-65
44. Ziegler A, Lefell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE, Brash DE: Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993, 90:4216-4220
45. Lubbe J, Reichel M, Burg G, Kleihues P: Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol 1994, 102:819-821
46. MacKie RM, Aitchinson T: Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br J Cancer 1982, 46:955-960
47. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
48. Slebos RJC, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJLM, Wagenaar SS, Van der Schueren RGJRA, Van Zandwijk N, Mooi WJ, Bos JL, Rodenhuis S: K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990, 323: 561-565
49. Lubbert M, Mirro J, Miller CW, Kahan J, Isaac G, Kitchingman G, Mertelsmann R, Herrmann F, McCormick F, Koeffler HP: N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood 1990, 75:1163-1169
50. Trimble WS, Johnson PW, Hozumi N, Roder JC: Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility. Nature 1986, 321:782-784
51. Van Elsas A, Nijman HW, Van der Minne CE, Mourer SJ, Kast WM, Melief CJM, Schrier PI: Induction and characterization of cytotoxic T-lymphocytes recognizing mutated p21ras peptide presented by HLA-A*0201. Int J Cancer 1995, 61:389-396